Latest News & Features
Big Pharma
Novartis has created a platform called Nerve Live that will tap into its “huge data pool” in order to aid drug development. 3 July 2018
Europe
Brexit has created many uncertainties in the IP arena and the CEO of the UK Intellectual Property Office is urging stakeholders to speak up, so that the office isn’t the “lone voice” advocating the importance of IP. 2 July 2018
Asia
Speaking to LSIPR Leena Menghaney, regional head of Médecins Sans Frontières’ Access Campaign in South Asia, explains the importance of a balanced IP policy in fostering healthy generic competition. 2 July 2018
Americas
Pharmaceutical companies AbbVie and Besins Healthcare have been ordered to pay the US Federal Trade Commission $448 million for using “sham litigation” to block access to generic versions of a testosterone drug. 2 July 2018
Americas
The US Court of Appeals for the Federal Circuit has ruled that a passing mention in the prior art of a formulation that references the claimed ingredient and administration may not be enough to invalidate a patent claim. 2 July 2018
Americas
Holland & Hart has added Loren Hulse as a partner to the firm’s Salt Lake City office. 2 July 2018
Europe
Private equity investor Advent International has agreed to acquire France-based Sanofi's European generics business Zentiva. 29 June 2018
Big Pharma
Mathys & Squire has added Peter Arch and Craig Titmus to the firm’s partnership. 29 June 2018
Big Pharma
Switzerland’s highest court held that new supplementary protection certificates for combination products should be governed by the relevant EU law, in a dispute over a Swiss SPC owned by Gilead Sciences. 28 June 2018
Americas
The US is leading the way in synthetic biology patent filings, according to a report released earlier this month from patent search software company PatSnap. 28 June 2018